Status:
COMPLETED
Reducing Anxiety Levels Through the Dharma Life App-Based and Mentor-Based Program Targeting Personality Characteristics: A Randomized Control Trial
Lead Sponsor:
Dharma Life Sciences LLC
Conditions:
Anxiety
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study was to examine whether an app- and mentor-based program reduced anxiety among individuals reporting difficulties with anxiety. For the intervention group, this study involve...
Eligibility Criteria
Inclusion
- Moderate to severe anxiety levels based on the BAI and GAD-7
Exclusion
- We excluded participants experiencing any of the following self-reported behaviors in the past 6 months: substance abuse, self-harm, harm or destruction of another person or their property, suicidal ideations, and feeling helpless after the death of a loved one
Key Trial Info
Start Date :
September 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2022
Estimated Enrollment :
73 Patients enrolled
Trial Details
Trial ID
NCT06138652
Start Date
September 1 2021
End Date
January 31 2022
Last Update
November 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dharma Life Sciences
New York, New York, United States, 10173